Christopher C. Chapman JR - 02 Aug 2023 Form 3 Insider Report for MIRA PHARMACEUTICALS, INC. (MIRA)

Role: Executive Chairman, Director
Signature: /s/ Michelle Yanez, Attorney-in-Fact for Christopher C. Chapman, Jr.
Issuer symbol: MIRA
Transactions as of: 02 Aug 2023
Net transactions value: $0
Form type: 3
Filing time: 02 Aug 2023, 17:52:21 UTC
Previous filing: 09 Jun 2023
Next filing: 21 Aug 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	MIRA	Common Stock						200,000	02 Aug 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	MIRA	Stock Option (right to buy)							02 Aug 2023	Common stock	220,000	$5.00	Direct	F1
holding	MIRA	Stock Option (right to buy)							02 Aug 2023	Common stock	60,000	$5.00	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vested and became exercisable as to 70,000 shares on June 15, 2022 and 50,000 shares on June 15, 2023. 50,000 of the remaining shares become exercisable on June 15, 2024 and 50,000 become exercisable on June 15, 2025.
F2	The option vested and became exercisable as to 20,000 shares on April 28, 2023, and becomes exercisable on the remaining 20,000 shares on April 28, 2024 and 20,000 shares on April 28, 2025.